An efficient method for synthesis of succinate-based MMP inhibitors

Organic Letters

Volumn 4, Issue 20, 2002, Pages 3347-3349

  Sibi, Mukund P ^a   Hasegawa, Hikaru ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; METALLOPROTEINASE; SUCCINIC ACID DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; STEREOISOMERISM; SYNTHESIS;

ENZYME INHIBITORS; METALLOENDOPEPTIDASES; MOLECULAR STRUCTURE; STEREOISOMERISM; SUCCINATES;

EID: 0037015437     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol026331t     Document Type: Article

References (31)

1. (a) Leung, D.; Abbenante, G.; Fairlie, D. P. J. Med. Chem. 2000, 43, 305.
2. (b) Michaelides, M. R.; Curtin, M. L. Curr. Pharm. Des. 1999, 5, 787.
3. (c) Foda, H. D.; Zucker, S. Drug Discovery Today 2001, 6, 478.
4. For a recent review article, see: Whittaker, M.; Floyd, C. D.; Brown, P.; Geraing, A. J. H. Chem. Rev. 1999, 99, 2735 and references therein.
5. Sibi, M. P.; Chen, J. J. Am. Chem. Soc. 2001, 123, 9472.
6. Crimmin, M. J.; Beckett, P. R.; Davis, M. H. British Bio-Technology Ltd.; WO 94 21,625; Chem. Abstr. 1995, 122, 188173y.
7. For work on radical addition to fumarates using imides derived from Kemps triacid, see: (a) Stack, J. G.; Curran, D. P.; Geib, S. V.; Rebek, J., Jr.; Ballester, P. J. Am. Chem. Soc. 1992, 114, 7007.
8. For examination of selectivity in radical addition to fumarates and related systems, see: (b) Porter, N. A.; Bruhnke, J. D.; Wu, W.-X.; Rosenstein, I. J.; Breyer, R. A.; McPhail, A. T. J. Am. Chem. Soc. 1992, 114, 7664.
9. (c) Giese, B.; Zehnder, M.; Roth, M.; Zeitz, H.-G. J. Am. Chem. Soc. 1990, 112, 6741.
10. (d) Porter, N. A.; Scott, D. M.; Lacher, B.; Giese, B.; Zeitz, H. G.; Lindner, H. J. J. Am. Chem. Soc. 1989, 111, 8311.
11. (e) Sibi, M. P.; Liu, P.; Ji, J.; Chen. J. J. Org. Chem. 2002, 67, 1738.
12. See Supporting Information for the synthesis of 1.
13. For an excellent recent review, see: Renaud, P.; Gerster, M. Angew. Chem., Int. Ed. 1998, 37, 2562. Also see: Radicals in Organic Synthesis; Renaud, P., Sibi, M. P., Eds.; Wiley-VCH: Weinheim, 2001; Vols. 1 and 2.
14. For an excellent recent review, see: Renaud, P.; Gerster, M. Angew. Chem., Int. Ed. 1998, 37, 2562. Also see: Radicals in Organic Synthesis; Renaud, P., Sibi, M. P., Eds.; Wiley-VCH: Weinheim, 2001; Vols. 1 and 2.
15. (c) Sibi, M. P.; Ji, J.; Sausker J. B.; Jasperse, C. P. J. Am. Chem. Soc. 1999, 121, 7517.
16. (d) Sibi, M. P.; Ji, J.; Wu, J. H.; Gürtler, S.; Porter, N. A. J. Am. Chem. Soc. 1996, 118, 9200.
17. Varying amounts (1-20%) of the ethyl radical addition/trapping product was also observed depending on the Lewis acid.
18. For a discussion on the origins of the high anti selectivity observed in the addition/trapping experiments, see ref 3.
19. The oxazolidinone functionality in compound 6 was selectively hydrolyzed to a known acid. Pratt, L. M.; Bowles, S. A.; Courtney, S. F.; Hidden, C.; Lewis, C. N.; Martin, F. M.; Todd, R. S. Synlett 1998, 531. See Supporting Information for details.
20. The amount of ethyl addition byproduct in entries 2-6, Table 2, varied from 1% to 10%. This is an indirect reflection of radical chain length.
21. The anti stereochemistry for the product was assigned on the basis of analogy.
22. For some selected examples of the synthesis of succinate-based MMP inhibitors, see: (a) Hilpert, H. Tetrahedron 2001, 57, 7675.
23. (b) Yamamoto, M.; Tsujishita, H.; Hori, N.; Ohishi, Y.; Inoue, S.; Ikeda, S.; Okada, Y. J. Med. Chem. 1998, 41, 1209.
24. (c) Levy, D. E.; Lapierre, F.; Liang, W.; Ye, W.; Lange, C. W.; Li, X.; Grobelny, D.; Casabonne, M.; Tyrrell, D.; Holme, K.; Nadzan, A.; Galardy, R. E. J. Med. Chem. 1998, 41, 199.
25. (d) Fray, M. J.; Burslem, M. F.; Dickinson, R. P. Bioorg. Med. Chem. Lett. 2001, 11, 567.
26. (e) Fray, M. J.; Dickinson, R. P. Bioorg. Med. Chem. Lett. 2001, 11, 571.
27. (f) McClure, K. F.; Axt, M. Z. Bioorg. Med. Chem. Lett. 1998, 8, 143.
28. (g) Steinman, D. H.; Curtin, M. L.; Garland, R. B.; Davidsen, S. K.; Heyman, H. R.; Holms, J. H.; Albert, D. H.; Magoc, T. J.; Nagy, I. B.; Marcotte, P. A.; Li, J.; Morgan, D. W.; Hutchins, C.; Summers, J. B. Bioorg. Med. Chem. Lett. 1998, 8, 2087.
29. (h) Pratt, L. M.; Beckett, P.; Bellamy, C. L.; Corkill, D. J.; Cosins, J.; Courtney, P. F.; Davies, S. J.; Davidson, A. H.; Drummond, A. H.; Helfrich, K.; Lewis, C. N. Mangan, M.; Martin, F. M.; Miller, K.; Nayee, P.; Ricketts, M. L.; Thomas, W.; Todd, R. S.; Whittaker, M. Bioorg. Med. Chem. Lett. 1998, 8, 1359.
30. Sibi, M. P.; Hasegawa, H.; Ghorpade, S. Org. Lett. 2002, 4, 3343.
31. 2, or TMSONHTMS gave low yields of BB-1101.